About Aganitha
Aganitha is a company based in Hyderabad (India) founded in 2017 by Ramarao Kanneganti, Prasad Chodavarapu, and Vikram Duvvoori. The company has 48 employees as of April 08, 2024. Aganitha offers products and services including Aganitha Igniva™, Genomics Analysis, Small Molecule Engineering, and Antibody Engineering. Aganitha operates in a competitive market with competitors including Atomwise, BioSymetrics, ArisGlobal, Cellumen and Systems Oncology, among others.
- Headquarter Hyderabad, India
- Employees 48 as on 08 Apr, 2024
- Founders Ramarao Kanneganti, Prasad Chodavarapu, Vikram Duvvoori
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aganitha Cognitive Solutions Private Limited
- Date of Incorporation 18 May, 2017
- Jurisdiction Serilingampally Hyderabad, Telangana, India
-
Annual Revenue
$670.94 K (USD)49.98as on Mar 31, 2023
-
Net Profit
$11.26 K (USD)-38.62as on Mar 31, 2023
-
EBITDA
$18.78 K (USD)-23.9as on Mar 31, 2023
-
Latest Funding Round
$15 K (USD), Grant
Jun 08, 2023
- Investors
-
Employee Count
48
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aganitha
Aganitha offers a comprehensive portfolio of products and services, including Aganitha Igniva™, Genomics Analysis, Small Molecule Engineering, and Antibody Engineering.
Platform for therapeutic design and biomarker research
Tools for analyzing genomic data in drug development
Services for designing novel small molecules
Solutions for antibody optimization and characterization
People of Aganitha
Unlock access to complete
Funding Insights of Aganitha
Investors in Aganitha
Aganitha has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Accenture Ventures Tech Next Challenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A challenge platform by Accenture for Autonomous AI startups.
|
Locked | Locked | Locked |
Investor details for Aganitha
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aganitha
Investment portfolio details for Aganitha
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aganitha
Detailed financials for Aganitha
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aganitha Comparisons
Peer comparison for Aganitha
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aganitha
Aganitha operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atomwise, BioSymetrics, ArisGlobal, Cellumen and Systems Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-driven platform for structure-based drug discovery is provided.
|
|
| Locked | Locked | Locked |
Provider of a cognitive computing-based biomedical intelligence platform
|
|
| Locked | Locked | Locked |
Drug development solutions are delivered via cognitive computing platform.
|
|
| Locked | Locked | Locked |
Systems biology solutions for drug safety and efficacy are provided.
|
|
| Locked | Locked | Locked |
Oncology focused drug discovery using biology and cognitive computing
|
Detailed competitors of Aganitha
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aganitha
Complete news archive for Aganitha
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aganitha
Aganitha was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Aganitha is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Vikram Duvvoori is the current CEO of Aganitha. They have also founded this company.
As of Apr 08, 2024, the latest employee count at Aganitha is 48.
Annual revenue of Aganitha is $670.94K as on Mar 31, 2023.
Provider of AI-powered drug discovery and development solutions. It offers computational biology and chemistry services, leveraging large language models and generative AI to design novel small molecules, antibodies, and other therapeutics. The companys platform integrates genomics, transcriptomics, proteomics, and organoid research data to accelerate the drug development process. Services include targetbiomarker research, virtual screening, antibody engineering, and various RNA and gene therapies. A focus on multiscale systems biology and a virtuous loop between in silico and wet lab approaches are key elements of its methodology. The company provides customizable platforms and solutions across the entire drug discovery value chain.
Aganitha's top competitors include Atomwise, BioSymetrics and ArisGlobal.
Aganitha offers Aganitha Igniva™, Genomics Analysis, Small Molecule Engineering, and Antibody Engineering.
Aganitha has 1 investor. Key investors include Accenture Ventures Tech Next Challenge.